When analyzing the expression on NK cells of the co-activating receptor CD122 (IL-2/15Rβ), we observed a decrease in the expression of this receptor for the melanoma group compared to the CTRL and ALD groups (p < 0.001); in mice treated with ALDARA, this receptor showed expression levels similar to those of the healthy group (Figure 3c). Here, IL2 is linked to melanoma.